3billion
Provides comprehensive rare disease genetic testing at an affordable price.
Launch date
Employees
Market cap
-
Enterprise valuation
$52—78m (Dealroom.co estimates Mar 2021.)
Company register number 2908100524
Seoul South Korea (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | Seed | |
$2.8m | Series A | ||
$10.0m | Series B | ||
$13.0m | Series C | ||
Total Funding | $25.8m |
Related Content
Recent News about 3billion
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.